{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&min-date=2021-10-21&max-answer.questionFirstMinisteriallyCorrected.=2021-12-16T12%3A18%3A50.663Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptId=17&min-date=2021-10-21&max-answer.questionFirstMinisteriallyCorrected.=2021-12-16T12%3A18%3A50.663Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&min-date=2021-10-21&max-answer.questionFirstMinisteriallyCorrected.=2021-12-16T12%3A18%3A50.663Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answeringDeptId=17&min-date=2021-10-21&max-answer.questionFirstMinisteriallyCorrected.=2021-12-16T12%3A18%3A50.663Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&min-date=2021-10-21&max-answer.questionFirstMinisteriallyCorrected.=2021-12-16T12%3A18%3A50.663Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&min-date=2021-10-21&max-answer.questionFirstMinisteriallyCorrected.=2021-12-16T12%3A18%3A50.663Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1366282", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1366282/answer", "answerText" : {"_value" : "<p>The Government has published <ins class=\"ministerial\">Ventilation of indoor spaces to stop the spread of coronavirus (COVID-19)<\/ins> <del class=\"ministerial\">Ventilation of indoor spaces on how to improve the spread of coronavirus (COVID-19)<\/del> in an online only format. This guidance stresses the importance of practical steps such as opening windows and doors; making sure small vents or grilles are open and not blocked; and ensuring that any mechanical ventilation system is working and maintained in line with manufacturers\u2019 instructions. Ventilation systems should bring fresh air in and not recirculate indoor air. In workplaces and non-domestic settings, ventilation should be considered alongside other control measures to reduce the risk of COVID-19.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4909", "label" : {"_value" : "Biography information for Lord Kamall"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Kamall"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1366282/answer/attachment/1", "fileName" : {"_value" : "Ventilation of indoor spaces to stop the spread of coronavirus (COVID-19) - GOV.UK.pdf"}
          , "title" : "Ventilation of indoor spaces to stop the spread of"}
        , "dateOfAnswer" : {"_value" : "2021-12-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1366282/answer/previousversion/38253", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4909", "label" : {"_value" : "Biography information for Lord Kamall"}
          }
          , "answeringMemberPrinted" : {"_value" : "Lord Kamall"}
          , "attachment" : {"_about" : "http://data.parliament.uk/resources/1366282/answer/previousversion/38253/attachment/1", "fileName" : {"_value" : "Ventilation of indoor spaces to stop the spread of coronavirus (COVID-19) - GOV.UK.pdf"}
            , "title" : "Ventilation of indoor spaces to stop the spread of"}
        }
        , "questionFirstAnswered" : [{"_value" : "2021-12-10T11:26:13.36Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-12-13T19:04:40.23Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-11-04", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus: Ventilation"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what steps they are taking to promote ventilation in buildings to minimise the spread of COVID-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4282", "label" : {"_value" : "Biography information for Lord Bourne of Aberystwyth"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Bourne of Aberystwyth"}
      ], "uin" : "HL3721"}
    , {"_about" : "http://data.parliament.uk/resources/1362994", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1362994/answer", "answerText" : {"_value" : "<p>Individual allocations for trusts will be determined once the respective final business cases have been reviewed and agreed. The timing and amount of funding allocations for each scheme are dependent on trusts\u2019 specific requirements. In total, pathfinder schemes have received public dividend capital of £94 million prior to the current financial year for fees and enabling works. In addition, <del class=\"ministerial\">West Hertfordshire Hospitals NHS Trust has<\/del> <ins class=\"ministerial\">pathfinder trusts have<\/ins> £117 million in confirmed allocations for 2021-22 and future years. Further requests for funding are currently being considered and will be subject to the appropriate governance process to ensure maximum value for taxpayers\u2019 money.<\/p><p>The pathfinder schemes are currently anticipated to start construction between 2023-24 and complete in the period 2026-28.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2021-11-01", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1362994/answer/previousversion/29120", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
          }
          , "answeringMemberConstituency" : {"_value" : "Charnwood"}
          , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        }
        , "questionFirstAnswered" : [{"_value" : "2021-11-01T14:24:35.003Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-12-01T16:38:32.913Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-10-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hospitals: Construction"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much funding he plans to make available to the eight pathfinder trusts in the New Hospital Programme to deliver new facilities; and what recent assessment he has made of adequacy of that planned funding.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4769", "label" : {"_value" : "Biography information for Daisy Cooper"}
      }
      , "tablingMemberConstituency" : {"_value" : "St Albans"}
      , "tablingMemberPrinted" : [{"_value" : "Daisy Cooper"}
      ], "uin" : "62856"}
    , {"_about" : "http://data.parliament.uk/resources/1362995", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1362995/answer", "answerText" : {"_value" : "<p>Individual allocations for trusts will be determined once the respective final business cases have been reviewed and agreed. The timing and amount of funding allocations for each scheme are dependent on trusts\u2019 specific requirements. In total, pathfinder schemes have received public dividend capital of £94 million prior to the current financial year for fees and enabling works. In addition, <del class=\"ministerial\">West Hertfordshire Hospitals NHS Trust has<\/del> <ins class=\"ministerial\">pathfinder trusts have<\/ins> £117 million in confirmed allocations for 2021-22 and future years. Further requests for funding are currently being considered and will be subject to the appropriate governance process to ensure maximum value for taxpayers\u2019 money.<\/p><p>The pathfinder schemes are currently anticipated to start construction between 2023-24 and complete in the period 2026-28.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2021-11-01", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1362995/answer/previousversion/29121", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
          }
          , "answeringMemberConstituency" : {"_value" : "Charnwood"}
          , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        }
        , "questionFirstAnswered" : [{"_value" : "2021-11-01T14:24:35.083Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-11-29T13:12:56.62Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-10-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hospitals: Construction"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will to publish a timeline for releasing funds for the detailed design and enabling works required from West Hertfordshire Hospitals NHS Trust and the other seven pathfinder trusts to help those trusts meet the New Hospital Programme\u2019s timescale.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4769", "label" : {"_value" : "Biography information for Daisy Cooper"}
      }
      , "tablingMemberConstituency" : {"_value" : "St Albans"}
      , "tablingMemberPrinted" : [{"_value" : "Daisy Cooper"}
      ], "uin" : "62857"}
    , {"_about" : "http://data.parliament.uk/resources/1362996", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1362996/answer", "answerText" : {"_value" : "<p>Individual allocations for trusts will be determined once the respective final business cases have been reviewed and agreed. The timing and amount of funding allocations for each scheme are dependent on trusts\u2019 specific requirements. In total, pathfinder schemes have received public dividend capital of £94 million prior to the current financial year for fees and enabling works. In addition, <del class=\"ministerial\">West Hertfordshire Hospitals NHS Trust has<\/del> <ins class=\"ministerial\">pathfinder trusts have <\/ins>£117 million in confirmed allocations for 2021-22 and future years. Further requests for funding are currently being considered and will be subject to the appropriate governance process to ensure maximum value for taxpayers\u2019 money.<\/p><p>The pathfinder schemes are currently anticipated to start construction between 2023-24 and complete in the period 2026-28.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
        }
        , "answeringMemberConstituency" : {"_value" : "Charnwood"}
        , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        , "dateOfAnswer" : {"_value" : "2021-11-01", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1362996/answer/previousversion/29122", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
          }
          , "answeringMemberConstituency" : {"_value" : "Charnwood"}
          , "answeringMemberPrinted" : {"_value" : "Edward Argar"}
        }
        , "questionFirstAnswered" : [{"_value" : "2021-11-01T14:24:35.13Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-12-01T16:38:23.543Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-10-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hospitals: Construction"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether it remains his policy for the pathfinder trusts to start construction in 2023 and be ready to open by 2027 at the latest as part of the New Hospital Programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4769", "label" : {"_value" : "Biography information for Daisy Cooper"}
      }
      , "tablingMemberConstituency" : {"_value" : "St Albans"}
      , "tablingMemberPrinted" : [{"_value" : "Daisy Cooper"}
      ], "uin" : "62858"}
    , {"_about" : "http://data.parliament.uk/resources/1362397", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1362397/answer", "answerText" : {"_value" : "<p>Consumption of any tobacco product is harmful and it is the Government\u2019s policy to support people to quit all forms of tobacco use. Oral tobacco, or snus, is banned in the United Kingdom under the Tobacco and Related Products Regulations 2016.<\/p><p>There is limited data on the health risks posed to smokers who switch to snus products. Evidence submitted on snus to the United States Food and Drug Administration states that there are still health risks involved with the use of snus. Although snus products contain significantly lower levels of harmful carcinogens than other smokeless tobacco products, the products contain nitrosamines, including NNN and NNK, which have been demonstrated to cause cancer, including cancers of the mouth. A copy of this evidence, <em>Modified Risk Tobacco Product (MRTP) ApplicationTechnical Project Lead (TPL) Review<\/em>, is attached.<\/p><p><em>Health risks of Scandinavian snus consumption (English summary)<\/em> from Norway shows that tobacco products such as oral tobacco contains carcinogenic substances which are associated with a number of adverse health effects. This is regardless of whether the individual is a smoker or not. A copy of this summary is attached.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4909", "label" : {"_value" : "Biography information for Lord Kamall"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Kamall"}
        , "attachment" : [{"_about" : "http://data.parliament.uk/resources/1362397/answer/attachment/1", "fileName" : {"_value" : "health-risks-of-scandinavian-snus-consumption-english-summary-pdf.pdf"}
          , "title" : "Health risks of Scandinavian snus consumption "}
        , {"_about" : "http://data.parliament.uk/resources/1362397/answer/attachment/2", "fileName" : {"_value" : "SMUSA-TPL-Review.pdf"}
          , "title" : "Modified Risk Tobacco Product Application (MRTPA)"}
        ], "dateOfAnswer" : {"_value" : "2021-11-15", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1362397/answer/previousversion/31943", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4909", "label" : {"_value" : "Biography information for Lord Kamall"}
          }
          , "answeringMemberPrinted" : {"_value" : "Lord Kamall"}
          , "attachment" : [{"_about" : "http://data.parliament.uk/resources/1362397/answer/previousversion/31943/attachment/1", "fileName" : {"_value" : "health-risks-of-scandinavian-snus-consumption-english-summary-pdf.pdf"}
            , "title" : "Health risks of Scandinavian snus consumption "}
          , {"_about" : "http://data.parliament.uk/resources/1362397/answer/previousversion/31943/attachment/2", "fileName" : {"_value" : "Modified-Risk-Tobacco-Product-Application-Technical-Project-Lead-Review-Swedish-Match-North-America.pdf"}
            , "title" : "Modified Risk Tobacco Product (MRTP) ApplicationTe"}
          ]}
        , "questionFirstAnswered" : [{"_value" : "2021-11-15T11:48:11.307Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2021-12-16T12:18:50.663Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-10-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Oral Tobacco: Health Hazards"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what evidence that they have, if any, which identifies the health risks posed to smokers who switch to snus products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/248", "label" : {"_value" : "Biography information for Lord Jones of Cheltenham"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Jones of Cheltenham"}
      ], "uin" : "HL3287"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}